膝关节假体设计更新能否提升生存率?澳大利亚骨科协会国家关节置换登记研究
该研究基于澳大利亚骨科协会国家关节置换登记系统(AOANJRR)1999年至2017年数据,对11对同一厂商新旧膝关节假体系统进行配对分析。结果显示,6对新型假体生存率优于旧型,3对无差异,2对新型翻修率更高。翻修指征中,磨损翻修有5对改善,不稳定性翻修无改善且4对更差。结论认为不应在缺乏稳健临床证据前广泛采用新设计。
要点
- 11对假体系统中仅6对新型生存率优于旧型,2对反而更差。
- 不稳定性翻修无改善,4对新型翻修率高于旧型。
- 广泛采用新设计前需等待稳健临床研究证据。
核心结论
- 新型膝关节假体系统的生存率并非必然优于旧系统,部分新型系统翻修率更高。
- 在缺乏稳健临床研究证明获益前,广泛采用新设计并不明智。
研究设计与样本
- 纳入至少2000例原发全膝关节置换(TKA)且随访至少5年的假体系统,排除内外翻限制型和铰链型设计。
- 共分析323955例TKA和11对新旧假体系统,其中6对为交叉韧带保留型、4对为后稳定型、1对为内侧轴型。
- 生存率采用Kaplan-Meier法计算,比较采用Cox比例风险模型。
主要发现
- 11对假体系统中,6对新型设计生存率改善,3对无差异,2对新型翻修率高于旧型。
- 磨损翻修分析中,5对假体系统改善,5对无差异,1对新型翻修率更高。
- 不稳定性翻修率无改善,7对新型与旧型无差异,4对新型翻修率更高。
- 髌股并发症翻修亚组分析中,2对改善,6对无差异,2对翻修率更高,1对因翻修数量不足无法计算。
关键数值与推荐
- 翻修定义为移除、更换或增加一个或多个假体组件的再次手术。
- 证据等级为Level III,治疗性研究。
临床怎么用
- 外科医生应意识到假体设计变更未必转化为更好的生存率,更换系统前需寻求生存率和/或功能改善的强有力证据。
- 医疗政策制定者和器械监管者应基于同行评议证据接受已确立实践的变更。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: TKA generally has excellent long-term survivorship. When a new knee system supersedes a previous model, increased survivorship, improved functional performance, or both may be expected, because key areas of design modification are often targeted to address wear, stability, and the patellofemoral articulation. However, not all design changes are beneficial, and to our knowledge, knee arthroplasty has not been systematically evaluated in the context of design changes that occur during the development of new knee arthroplasty systems. QUESTIONS/PURPOSES: Using the Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) we performed multiple old-to-new comparisons of frequently used contemporary knee implants to ask: (1) does overall prosthesis survivorship free from revision increase when a new knee prosthesis system is introduced to replace a prior prosthesis system? (2) Has survivorship free from revision improved for the revision indications of wear, instability, and patellofemoral articulation issues, where development efforts have been concentrated? METHODS: Data from the AOANJRR from September 1999 to December 2017 were used to compare the survivorship of prostheses free from revision at a maximum of 17 years in procedures where a new design model was introduced to replace a prior knee system from the same manufacturer. Only prosthesis systems used in a minimum of 2000 primary TKA procedures for osteoarthritis that had a minimum of 5 years of follow-up were included. Varus-valgus constrained and hinge TKA designs were excluded. Cruciate-retaining, posterior-stabilized, and medial pivot-design knees were considered separately. The new and old prosthesis systems were paired for analysis. Survivorship was calculated with Kaplan Meier estimates and comparisons were performed using the Cox proportional hazards method. Subanalyses according to the three main revision indications were performed, and where possible, analyses were performed based on polyethylene types (highly cross-linked polyethylene and ultra-high-molecular-weight polyethylene), combined and separated. Revision was defined as a reoperation of a previous knee arthroplasty in which one or more of the components was removed, replaced, or added. There were 323,955 TKA procedures and 11 new prosthesis system designs that were introduced to replace an earlier knee system from the same manufacturer. Of these prosthesis system pairs, six were cruciate-retaining prostheses, four were posterior-stabilized designs, and one was a medial pivot design. RESULTS: Six of the 11 knee system pairs showed improved survivorship with the new design, three were no different, and in two, the newer prosthesis systems had a higher rate of revision than the old one did. When revision for wear was analyzed, five prosthesis systems showed improvement, five were no different, and one had a higher rate of revision than the previous system did. There was no improvement in the rate of revision for instability; seven new prosthesis systems showed no difference from the previous system and four new prosthesis systems had a higher rate of revision than the previous system did. A subanalysis of revision for patellofemoral complications showed improvement in two comparisons, no difference in six, and a higher revision rate in two; one could not be calculated because of an insufficient number of revisions for this reason. CONCLUSIONS: It is difficult to predict whether a new system will demonstrate better survival than a previous one, and widespread uptake of a new design before a benefit is shown in robust clinical studies is unwise. Similarly, adoption of a new system for which there is no difference in survivorship from a previous model may be premature because a new device may have associated unknown and unintended consequences. Healthcare policy makers and therapeutic device regulators should similarly be guided by results and seek out peer-reviewed evidence before accepting change to established practice. Surgeons must be aware that implant changes may not translate into better survivorship and must seek compelling evidence of improvement in survival and/or function before changing systems. LEVEL OF EVIDENCE: Level III, therapeutic study.
引用
- Lewis PL, Graves SE, de Steiger RN, et al. Does Knee Prosthesis Survivorship Improve When Implant Designs Change? Findings from the Australian Orthopaedic Association National Joint Replacement Registry. Clin Orthop Relat Res. 2020. PMID: 32324669. doi:10.1097/CORR.0000000000001229
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。